Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 3-(2,4-dimethoxybenzylidene)anabaseine
2. Dmxba
3. Gts 21
4. Gts-21
1. 156223-05-1
2. Gts 21 Dihydrochloride
3. Dmxba
4. Gts-21 (dihydrochloride)
5. Dmxb-anabaseine
6. 3-[(5e)-5-[(2,4-dimethoxyphenyl)methylidene]-3,4-dihydro-2h-pyridin-6-yl]pyridine;dihydrochloride
7. Dmbx-a
8. Dmbx-anabaseine
9. (e)-3-(2,4-dimethoxybenzylidene)-3,4,5,6-tetrahydro-2,3'-bipyridine Dihydrochloride
10. 3-(2,4-dimethoxybenzylidene)-3,4,5,6-tetrahydro-2,3'-bipyridine Dihydrochloride
11. 156743-66-7
12. Gts-21 2hcl
13. Gts 21
14. Dmxb
15. Schembl2561893
16. Schembl12274790
17. Ex-a5724
18. Hy-14564a
19. Akos037515500
20. Cs-5486
21. (e)-3-((2,4-dimethoxyphenyl)methylene)-3,4,5,6-tetrahydro-2,3'-bipyridine Dihydrochloride
22. 2,3'-bipyridine, 3-((2,4-dimethoxyphenyl)methylene)-3,4,5,6-tetrahydro-, Dihydrochloride, (e)-
23. Ac-31954
24. Gts-21, >=97% (hplc)
25. 3-(2,4-dimethoxybenzylidene)anabaseine Dihydrochloride
26. 3-(2,4-dimethoxybenzylidene)-anabaseine Dihydrochloride
27. 3-(3-(2,4-dimethoxybenzyl)-3,4,5,6-tetrahydropyridin-2-yl)pyridine Dihydrochloride
28. (e)-3-(3-(2,4-dimethoxybenzylidene)-3,4,5,6-tetrahydropyridin-2-yl)pyridine Dihydrochloride
| Molecular Weight | 381.3 g/mol |
|---|---|
| Molecular Formula | C19H22Cl2N2O2 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 4 |
| Exact Mass | 380.1058333 g/mol |
| Monoisotopic Mass | 380.1058333 g/mol |
| Topological Polar Surface Area | 43.7 Ų |
| Heavy Atom Count | 25 |
| Formal Charge | 0 |
| Complexity | 447 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 1 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 3 |
Nicotinic Agonists
Drugs that bind to and activate nicotinic cholinergic receptors (RECEPTORS, NICOTINIC). Nicotinic agonists act at postganglionic nicotinic receptors, at neuroeffector junctions in the peripheral nervous system, and at nicotinic receptors in the central nervous system. Agents that function as neuromuscular depolarizing blocking agents are included here because they activate nicotinic receptors, although they are used clinically to block nicotinic transmission. (See all compounds classified as Nicotinic Agonists.)
ABOUT THIS PAGE
30
PharmaCompass offers a list of 3-2,4-Dimethoxybenzylidene-Anabaseine API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right 3-2,4-Dimethoxybenzylidene-Anabaseine manufacturer or 3-2,4-Dimethoxybenzylidene-Anabaseine supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred 3-2,4-Dimethoxybenzylidene-Anabaseine manufacturer or 3-2,4-Dimethoxybenzylidene-Anabaseine supplier.
PharmaCompass also assists you with knowing the 3-2,4-Dimethoxybenzylidene-Anabaseine API Price utilized in the formulation of products. 3-2,4-Dimethoxybenzylidene-Anabaseine API Price is not always fixed or binding as the 3-2,4-Dimethoxybenzylidene-Anabaseine Price is obtained through a variety of data sources. The 3-2,4-Dimethoxybenzylidene-Anabaseine Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A GTS 21 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of GTS 21, including repackagers and relabelers. The FDA regulates GTS 21 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. GTS 21 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A GTS 21 supplier is an individual or a company that provides GTS 21 active pharmaceutical ingredient (API) or GTS 21 finished formulations upon request. The GTS 21 suppliers may include GTS 21 API manufacturers, exporters, distributors and traders.
click here to find a list of GTS 21 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A GTS 21 DMF (Drug Master File) is a document detailing the whole manufacturing process of GTS 21 active pharmaceutical ingredient (API) in detail. Different forms of GTS 21 DMFs exist exist since differing nations have different regulations, such as GTS 21 USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A GTS 21 DMF submitted to regulatory agencies in the US is known as a USDMF. GTS 21 USDMF includes data on GTS 21's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The GTS 21 USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of GTS 21 suppliers with USDMF on PharmaCompass.
GTS 21 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of GTS 21 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right GTS 21 GMP manufacturer or GTS 21 GMP API supplier for your needs.
A GTS 21 CoA (Certificate of Analysis) is a formal document that attests to GTS 21's compliance with GTS 21 specifications and serves as a tool for batch-level quality control.
GTS 21 CoA mostly includes findings from lab analyses of a specific batch. For each GTS 21 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
GTS 21 may be tested according to a variety of international standards, such as European Pharmacopoeia (GTS 21 EP), GTS 21 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (GTS 21 USP).
